DECYST
associated with 2 other trademarks
Pharmaceuticals for the treatment of Cystic Fibrosis, Rhinosinusitis, Chronic Obstructive Pulmonary Disease, Paroxysmal Nocturnal Hemoglobinuria, Fami...

Words that describe this trademark:

obstructive pulmonary disease  treatment cystic fibrosis  paroxysmal nocturnal hemoglobinuria  chronic obstructive pulmonary  pulmonary disease  cystic fibrosis  pharmaceuticals  disease  fibrosis  rhinosinusitis 

Serial Number:

76453612

Mark:

DECYST

Status:

Abandoned-No Statement of Use filed

Status Date:

10-15-2005

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals for the treatment of Cystic Fibrosis, Rhinosinusitis, Chronic Obstructive Pulmonary Disease, Paroxysmal Nocturnal Hemoglobinuria, Familial Hypercholesterolemia, Tay-Sachs Disease, viral diseases, neoplastic diseases, Hereditary Myeloperoxidase Deficiency, Congenital Insulin Resistance, Nephrogenic Diabetes Insipidus, Hemochromatosis, Gitelman's Syndrome, a1-antitryspin Deficiency, Cystinuria and all other disorders associated with retention of misfolded proteins in the endoplasmic reticulum

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

07-22-2003

Mark Drawing Status:

Typed Drawing

Abandon Date:

10-15-2005

Business Name:

CHOATE, HALL & STEWART

Correspondent Name:

Recent Trademark filings by this company